CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...